TABLE 2.

Implementation to antidiabetics, antihypertensive drugs, and statins at 6, 12, 18, and 24 months post-inclusion.

	Time since inclusion, months (m)	Number of patients	Implementation in group A (intervention lasted 12 months) (%)	Implementation in group B (intervention lasted 6 months) (%)	Difference (Δ) (%)	95% CI (%)
Antidiabetics	6	37	92.5	87.4	5.1	3.7	6.5%
	12	31	93.8	86.8	7.0	5.7	8.3%
	18	24	89.1	86.2	2.9	1.7	4.1%
	24	21	88.6	85.6	3.0	1.7	4.4%
Antihypertensive drugs	6	34	95.9	94.2	1.7	0.7	2.8%
	12	30	97.9	92.1	5.8	4.8	6.7%
	18	23	95.9	89.5	6.5	5.4	7.6%
	24	20	94.4	85.9	8.5	6.6	10.7%
Statins	6	31	95.4	96.4	−1.1	−1.8	−0.2%
	12	25	95.0	95.4	−0.4	−1.7	0.7%
	18	18	95.1	94.2	0.9	0.1	1.8%
	24	14	93.7	92.6	1.1	0.1	2.4%

NB: CI, confidence interval.